Percutaneous device closure of abernethy malformation-A treatable cause of hepatopulmonary syndrome

Simple item page
dc.contributor.authorVenkateshwaran, S
dc.contributor.authorKrishnamoorthy, KM
dc.contributor.authorSivasankaran, S
dc.date.accessioned2017-03-10T03:27:58Z
dc.date.available2017-03-10T03:27:58Z
dc.date.issued2014
dc.description.abstractAn eight-year-old girl was evaluated for unexplained cyanosis. A contrast echo was suggestive of pulmonary arteriovenous fistula. Further evaluation revealed Abernethy malformation (type 2) leading to hepatopulmonary syndrome. Percutaneous device closure of Abernethy malformation was done after anatomical and physiological evaluation of the portal circulation. Prior to closure, it is important to ensure adequate portal radicals into the liver and normal portal pressure after test balloon occlusion. Subcostal echocardiography can diagnose and guide device closure of Abernethy malformation, a treatable cause of hepatopulmonary syndrome. (c) 2013 Wiley Periodicals, Inc.
dc.identifier.citation83 ,6;968-970en_US
dc.identifier.uri10.1002/ccd.25275
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/10203
dc.publisherCATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
dc.subjectCardiovascular System & Cardiology
dc.titlePercutaneous device closure of abernethy malformation-A treatable cause of hepatopulmonary syndrome
Files
Collections
Journal Articles